Norges Bank’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
|
|||||
|
2023
Q2 | $14.8M | Sell |
|
|||||
|
2023
Q1 | $15M | Sell |
|
|||||
|
2022
Q4 | $7.8M | Buy |
|
|||||
|
2022
Q3 | $4.99M | Hold |
|
|||||
|
2022
Q2 | $6.04M | Buy |
|
|||||
|
2022
Q1 | $6.16M | Sell |
|
|||||
|
2021
Q4 | $5.77M | Hold |
|
|||||
|
2021
Q3 | $22M | Buy |
|
|||||
|
2021
Q2 | $30.2M | Buy |
|
|||||
|
2021
Q1 | $19.3M | Sell |
|
|||||
|
2020
Q4 | $24.8M | Sell |
|
|||||
|
2020
Q3 | $20.5M | Sell |
|
|||||
|
2020
Q2 | $37.1M | Sell |
|
|||||
|
2020
Q1 | $36M | Sell |
|
|||||
|
2019
Q4 | $52.2M | Buy |
|
|||||
|
2019
Q3 | $9.55M | Buy |
|